GRTS - Gritstone Oncology - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

55.01M

Cash

145.8M

Avg Qtr Burn

-30.65M

Short % of Float

5.08%

Insider Ownership

2.43%

Institutional Own.

53.37%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
GRANITE Details Solid tumor/s, Colorectal cancer , Gastric cancer, Cancer, Non-small cell lung carcinoma Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SLATE Details Solid tumor/s, Colorectal cancer , Lung cancer, Cancer	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
samRNA Details Infectious disease, COVID-19	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.